NCEL

$2.69

Market ClosedAs of Mar 17, 8:00 PM UTC

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.

Overview Intraday AnalysisPRO IntelligencePRO Ask AIPRO

Recent News

Simply Wall St.

Simply Wall St.

Owning 58% in NewcelX Ltd. (NASDAQ:NCEL) means that insiders are heavily invested in the company's future

Key Insights NewcelX's significant insider ownership suggests inherent interests in company's expansion 58% of the...

Positive press. Headlines skewed toward growth and analyst upgrades.